Crusia

Crusia (Enoxaparin Sodium) is an anticoagulant medication used to prevent and treat blood clots. It is administered intravenously or subcutaneously for effective blood thinning.

Crusia is primarily used to prevent and treat deep vein thrombosis (DVT) and pulmonary embolism. It is also used during certain medical procedures to reduce the risk of blood clots forming. Enoxaparin Sodium, the active ingredient, works by thinning the blood to prevent clots from developing.

Common effects of Crusia may include bruising, pain, or swelling at the injection site. Some users may experience bleeding more easily than usual. It is important to monitor for any signs of unusual bleeding or bruising.

Crusia should be used with caution in patients with a history of bleeding disorders or recent surgery. It is important to follow the prescribed dosage and administration instructions carefully. Always consult a healthcare provider before starting or stopping this medication.

Crusia may interact with other blood-thinning medications, nonsteroidal anti-inflammatory drugs (NSAIDs), and certain antibiotics. Alcohol consumption should be limited as it can increase the risk of bleeding. Always inform your healthcare provider about all medications you are taking.